Clinical Trials for Recurrent Nasopharyngeal Carcinoma

Find clinical trials for recurrent nasopharyngeal carcinoma. Discover research opportunities and treatment options in your area.

10 Active Trials Found

Showing 10 trials on this page

Page 1 of 1

Testing Nivolumab and Ipilimumab Immunotherapy With or Without the Targeted Drug Cabozantinib in Recurrent, Metastatic, or Incurable Nasopharyngeal Cancer

NCT ID: NCT05904080

This clinical trial is studying how well a combination of two immunotherapy drugs, nivolumab and ipilimumab, works when given with or without a targeted drug called cabozantinib in patients with na...

Recruiting

Phase: PHASE2 Type: interventional Locations: Chicago, Illinois, United States, Charleston, South Carolina, United States +101 more

Testing the Addition of BMS-986016 (Relatlimab) to the Usual Immunotherapy After Initial Treatment for Recurrent or Metastatic Nasopharyngeal Cancer

NCT ID: NCT06029270

This clinical trial is exploring whether adding a new drug called BMS-986016 (relatlimab) to the usual immunotherapy can help patients with nasopharyngeal cancer that has returned or spread to othe...

Recruiting

Phase: PHASE2 Type: interventional Locations: Chicago, Illinois, United States, Oklahoma City, Oklahoma, United States +78 more

Adjuvant vs Surgery Only in Early-stage Recurrent NPC

NCT ID: NCT06228079

This clinical trial is investigating whether adding an extra treatment called adjuvant therapy can help patients with early-stage recurrent nasopharyngeal carcinoma (NPC) do better compared to just...

Recruiting

Phase: PHASE3 Type: interventional Locations: Shanghai, , China, Shanghai, , China +5 more

Neoadjuvant vs Adjuvant in Locally Advanced Recurrent NPC

NCT ID: NCT06235203

This clinical trial is studying the best way to treat patients with locally advanced recurrent nasopharyngeal carcinoma (NPC), which is a type of throat cancer that has come back after initial trea...

Recruiting

Phase: PHASE3 Type: interventional Locations: Shanghai, , China, Fuzhou, Fujian, China +5 more

PD-1 Antibody Combined With Chemoradiotherapy in Recurrent Nasopharyngeal Carcinoma Patients

NCT ID: NCT03907826

This clinical trial is studying the combination of a PD-1 antibody and chemoradiotherapy to see if it is more effective than chemoradiotherapy alone for patients with recurrent nasopharyngeal carci...

Recruiting

Phase: PHASE3 Type: interventional Locations: Guangzhou, Guangdong, China, Beijing, , China +11 more

Camrelizumab and Chemotherapy Combined With Endoscopic Surgery for Recurrent Nasopharyngeal Carcinoma

NCT ID: NCT05011227

This clinical trial is studying a new treatment approach for patients with recurrent nasopharyngeal carcinoma, a type of cancer that comes back after initial treatment. The researchers want to see ...

Recruiting

Phase: PHASE2 Type: interventional Locations: Nanning, Guangxi, China, Nanchang, Jiangxi, China +5 more

Testing Nivolumab and Ipilimumab Immunotherapy With or Without the Targeted Drug Cabozantinib in Recurrent, Metastatic, or Incurable Nasopharyngeal Cancer

NCT ID: NCT06010095

This clinical trial is studying the effectiveness of two immunotherapy drugs, nivolumab and ipilimumab, with or without a targeted therapy called cabozantinib, in treating patients with nasopharyng...

Not yet recruiting

Phase: Phase 2 Type: interventional

Transnasal Endoscopic Surgery Combined With Adjuvant Immunotherapy for Recurrent NPC

NCT ID: NCT05350891

This clinical trial is investigating a new treatment approach for patients with recurrent nasopharyngeal carcinoma (NPC), which is a type of cancer that affects the area behind the nose and above t...

Recruiting

Phase: PHASE2 Type: interventional Locations: Nanning, Guangxi, China, Nanchang, Jiangxi, China +6 more

Toripalimab for Local-regional Recurrent Nasopharyngeal Carcinoma

NCT ID: NCT04376866

This clinical trial is studying a treatment for patients with a specific type of cancer called recurrent nasopharyngeal carcinoma, which means the cancer has come back in the area around the throat...

Recruiting

Phase: PHASE3 Type: interventional Locations: Nanning, Guangxi, China

Early Recurrent Nasopharyngeal Cancer: the Effect of Surgery vs IMRT

NCT ID: NCT04215510

This clinical trial is studying the best treatment option for patients with recurrent nasopharyngeal cancer, which is a type of cancer that comes back after initial treatment. Researchers are compa...

Not yet recruiting

Phase: PHASE3 Type: interventional Locations: Shanghai, Shanghai, China, Fuzhou, Fujian, China +1 more

Related Conditions

Breast Cancer View clinical trials → Stroke View clinical trials → Obesity View clinical trials → Cancer View clinical trials → Healthy View clinical trials → Prostate Cancer View clinical trials →

Search All Trials Browse All Conditions